HU-308 | Interleukin Related interleukin-related.com

Product Name :
HU-308

Search keywords :
HU-308

drugId :
null

Target Vo:
Cannabinoid CB2 receptor

Target Vo Short Name :
CB2

Moa_Name:
Cannabinoid CB2 receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Panag Pharma

Active Company_Name :
Panag Pharma

Active Indication_Name:
Xerophthalmia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
F4/80 Rat mAb In Vivo
Tocilizumab Biological Activity
MLKL Antibody: MLKL Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to MLKL. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts